-
Mashup Score: 0Wolters Kluwer Health - 11 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, RheumatologyTweet-
New in #PAIN: Stimulated whole-blood cytokine/chemokine responses are associated with interstitial cystitis/bladder pain syndrome phenotypes and features of #nociplastic pain https://t.co/HUAdOfVcNp @kren27
-
-
Mashup Score: 0Ketamine infusions and bladder complications - 1 year(s) ago
Consensus guidelines for ketamine infusions in acute and chronic pain were published in 2018.[1 2][1] Non-medical ketamine use can cause cystitis, rarely requiring cystectomy.[3][2] Data on cystitis in patients receiving ketamine for acute and chronic pain are lacking. The objective of this
Categories: Anesthesiology, Latest HeadlinesTweet
-
Mashup Score: 0
“I think people can feel like they’re all alone, or they have something that’s uncommon, and it may not be,” says J. Quentin Clemens, MD, FACS, MSCI.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 3
Patients with COVID-19 reported experiencing severe genitourinary symptoms during infection, and new or worsening overactive bladder symptoms after recovery, according to recent findings from two studies. The data were presented at the American Urological Association meeting.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update - 3 year(s) ago
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 8Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update - 3 year(s) ago
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update - 3 year(s) ago
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update - 3 year(s) ago
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update - 3 year(s) ago
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update - 3 year(s) ago
The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…
Source: Urology NewsCategories: Latest Headlines, UrologyTweet
New in #PAIN: Stimulated whole-blood cytokine/chemokine responses are associated with interstitial cystitis/bladder pain syndrome phenotypes and features of nociplastic pain https://t.co/UCq9PX4r7n